Exploring the Future of IBD Care: The Role of JAK Inhibitors
| Overview / Abstract: |
Advance your understanding on new and innovative approaches to care, focusing on the role of JAK Inhibitors in the treatment of IBD. Leading US gastroenterology faculty recently gave a series of lectures across the country on the latest research and treatment regimen recommendations in IBD to enhance optimal health outcomes. Thomas Ullman, MD, Chief of the Division of Gastroenterology at Montefiore Medical Center/Albert Einstein College of Medicine in new York City, will review and discuss the latest research in this recorded live Visiting Professorship which includes a downloadable resource. |
|
Expiration |
Nov 26, 2020 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online |
|
Credits / Hours |
1.0 |
|
Accreditation |
ACCME |
|
Is This Activity Certified for "Live" Credit? |
YES |
|
Presenters / Authors / Faculty |
Thomas Ullman, MD |
|
Activity Specialities / Related Topics |
Family Medicine, Gastroenterology / GI, Immunology / Immunosuppression, Internal Medicine, Primary Care |
|
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Gilead Sciences, Inc. |
|
Keywords / Search Terms |
ACHL inflammatory disease, inflammatory bowel disease, IBD, crohn’s disease, ulcerative colitis, signaling pathway, JAK inhibitor, inflammatory diseases, autoimmune disorders, janus kinase, therapies, immune-mediated inflammatory diseases, JAK1, JAK2, JAK3, TYK2, JAK/STAT signaling, cytokine-mediated inflammatory diseases, DMARDs, chronic inflammation, emerging therapies, novel gastroenterology drugs, gastroenterology, Ullman, MD Free CE CME Live CE CME |
|